oncolytic virus therapy targeting CD30 (Goethe-University Frankfurt)

N/A

Report date: 2025/06/11 11:03:59

Base Information

Drug Nameoncolytic virus therapy targeting CD30 (Goethe-University Frankfurt)

Drug Alias Nameoncolytic vesicular stomatitis virus therapy targeting CD30 (Goethe-University Frankfurt)oncolytic measles virus therapy targeting CD30 (Goethe-University Frankfurt)VSV-CD30MV-CD30

ClassificationBiologics > Oncolytic virus

Mechanisms of ActionTumor necrosis factor receptor superfamily member 8 modulatorsImmunostimulants

TargetsTumor necrosis factor receptor superfamily member 8

Therapy Area/IndicationsHodgkin Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGoethe University Frankfurt am Main Center of Health Sciences

China Registration ClassN/A

Develop Information

Active CompaniesGoethe University Frankfurt am Main Center of Health Sciences

Inactive CompaniesN/A

Active IndicationsHodgkin Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A